GF Fund Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
GF Fund Management's PBYI Position: Q3 2026 in Review
GF Fund Management increased its Puma Biotechnology (PBYI) stake by 8.8% in Q3 2026, buying an estimated $836 and bringing the position to 1,175 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #534.
GF Fund Management first reported a position in PBYI in Q4 2025 and has held it in 4 quarters since. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- GF Fund Management held 1,175 shares of Puma Biotechnology worth $11.7K as of Q3 2026.
- GF Fund Management bought 95 Puma Biotechnology shares in Q3 2026, an estimated $836.
- Puma Biotechnology made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #534 holding.
- GF Fund Management first reported a position in Puma Biotechnology in Q4 2025 and has held it in 4 quarters since.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.